← SynDRA
GSK-J2
SynDRA canonical compound SYN0078985 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | histone demethylase inhibitor |
|---|
Mechanisms of action (all sources)
- histone demethylase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- MELK
- MAPK1
- PRKAA2
- OXSR1
- PAK4
- PAK5
- PAK6
- PBK
- PDPK1
- PIM1
- PIM2
- PIM3
- PLK1
- PLK4
- POLK
- PRKACA
- NEK2
- RIOK2
- RPS6KA3
- SLK
- STK10
- STK16
- STK17A
- STK25
- STK26
- STK38
- STK4
- TNIK
- VRK1
- VRK2
- NEK6
- CAMK1D
- CAMK1G
- MAPK6
- CAMK2A
- CAMK2B
- CAMK2D
- CAMK2G
- CAMK4
- CAMKK2
Cross-references
Synonyms
- orb1709546
- SCHEMBL15937902
- SCHEMBL29714501
- CHEBI:131154
- EX-A7232
- UFC85452
- HY-15648A
- AKOS024458293
- CS-3260
- NCGC00351549-04
- DA-63949
- MS-26480
- F85052
- T11476
- BRD-K82484347-001-01-2
- 3-[[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid
- sodium 3-[[2-pyridin-3-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoate
- T86529
- GSK-J2 (sodium)
- CHEBI:95076
- CS-0107079
- HY-15648I
- orb2566155
- HMS3426E11
Look up GSK-J2 in the interactive SynDRA portal →